Use of imidazol-2-thiones for the preparation of a medicament for reducing myocardial stunning
申请人:MERRELL DOW PHARMACEUTICALS INC.
公开号:EP0284925A2
公开(公告)日:1988-10-05
Certain imidazol-2-thiones are reported to reduce reperfusion injury which is the injury which occurs when molecular oxygen is reintroduced into an ischemic tissue. These compounds could be to prevent much of the damage which occurs to the heart of a heart attack victim.
据报道,某些咪唑-2-硫酮能减轻再灌注损伤,即分子氧重新进入缺血组织时发生的损伤。这些化合物可以防止心脏病患者心脏受到的大部分损伤。